What role does CYP2C19 play in allergy?

CYP2C19 is a cytochrome P450 enzyme primarily known for metabolizing drugs such as proton pump inhibitors (omeprazole) and clopidogrel. Its direct role in allergy is not well established. Some mechanistic studies suggest it may metabolize endogenous substrates like arachidonic acid derivatives or influence immune pathways, but evidence is weak and largely speculative. No strong human studies or GWAS have consistently linked CYP2C19 variants to allergic conditions like rhinitis, asthma, or food allergies. Consumer DNA tests that claim such associations often rely on preliminary or indirect data, blurring the line between marketing and evidence. For allergy diagnosis, IgE testing, skin prick tests, and clinical evaluation remain the gold standard. CYP2C19 genotyping is clinically relevant only for drug dosing, not for allergy prediction or management. Caveat: Do not use CYP2C19 genetic results to guide allergy treatment decisions.